Jais Oliver Berg
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jais Oliver Berg has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Belinda K. Mössner
Department of Clinical Microbiology, Odense University Hospital, Odense, and
1 shared publicationFinn Gottrup
Department of Plastic Surgery, University Center of Wound Healing, Odense University Hospital, Odense
1 shared publicationG. Schmidt
Department of Plastic Surgery and Burn Unit, Copenhagen University Hospital, Rigshospitalet, Denmark
1 shared publicationHans J. Kolmos
Department of Clinical Microbiology, Odense University Hospital, Odense, and
1 shared publication- Jørgen Lauridsen
Department of Economics, University of Southern Denmark, Odense, Denmark
1 shared publication K.T. Drzewiecki
Department of Plastic Surgery and Burn Unit, Copenhagen University Hospital, Rigshospitalet, Denmark
1 shared publication
Latest Publications
- 1 December 2008
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 61 (12) , 1512-1515
Allogeneic split-skin grafting in stem cell transplanted patients
- 1 December 2008
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 61 (12) , 1512-1515
Allogeneic split-skin grafting in stem cell transplanted patients
- 29 September 2006
- Published by Wiley in Wound Repair and Regeneration
- Vol. 14 (5) , 581-585
Antibacterial properties of EMLA® and lidocaine in wound tissue biopsies for culturing
If a tissue biopsy from a chronic wound is sampled for culture, the antibacterial properties of local anesthetics may pose a problem in producing false‐negative results. The purpose of this study was to investigate the effects of EMLA® (AstraZeneca) and lidocaine on common wound pathogenic bacteria. An in vitro study of a total of 25 clinical isolates and ATCC reference strains of Staphylococcus aureus (including methicillin‐resistant S. aureus), Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pyogenes was conducted. The isolates were exposed to the local anesthetic drugs (and some of their contents separately) at 35°C over a 24‐hour period and time–kill curves were recorded. No culture media were used and saline was used for controls. EMLA® was found to have a rapid acting and powerful antibacterial effect and should not be used before culturing tissue samples. Lidocaine 1% was found not to inhibit the bacterial strains when exposure time was held below 2 hours. We conclude that culturing tissue from a wound biopsy is safe within 2 hours when a pure, preservative‐free lidocaine 1% solution is used.
- 29 September 2006
- Published by Wiley in Wound Repair and Regeneration
- Vol. 14 (5) , 581-585
Antibacterial properties of EMLA® and lidocaine in wound tissue biopsies for culturing
If a tissue biopsy from a chronic wound is sampled for culture, the antibacterial properties of local anesthetics may pose a problem in producing false‐negative results. The purpose of this study was to investigate the effects of EMLA® (AstraZeneca) and lidocaine on common wound pathogenic bacteria. An in vitro study of a total of 25 clinical isolates and ATCC reference strains of Staphylococcus aureus (including methicillin‐resistant S. aureus), Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pyogenes was conducted. The isolates were exposed to the local anesthetic drugs (and some of their contents separately) at 35°C over a 24‐hour period and time–kill curves were recorded. No culture media were used and saline was used for controls. EMLA® was found to have a rapid acting and powerful antibacterial effect and should not be used before culturing tissue samples. Lidocaine 1% was found not to inhibit the bacterial strains when exposure time was held below 2 hours. We conclude that culturing tissue from a wound biopsy is safe within 2 hours when a pure, preservative‐free lidocaine 1% solution is used.
- 28 August 2006
- Vol. 168 (35) , 2924
[Picture of the month: rupture of the pectoralis major].
- 6 July 2005
- Published by Springer Nature in European Journal of Plastic Surgery
- Vol. 28 (2) , 99-104
Primary cutaneous carcinosarcoma: review and presentation of a case with emphasis on clinical characteristics and management
- 6 July 2005
- Published by Springer Nature in European Journal of Plastic Surgery
- Vol. 28 (2) , 99-104
Primary cutaneous carcinosarcoma: review and presentation of a case with emphasis on clinical characteristics and management
- 23 August 2004
- Vol. 166 (35) , 3006-7
[Duodeno-renal fistula as a complication of duodenal foreign bodies].
- 23 August 2004
- Vol. 166 (35) , 3006-7
[Duodeno-renal fistula as a complication of duodenal foreign bodies].